Theratechnologies Inc. (TSE:TH – Get Free Report) shares rose 1.9% during trading on Thursday . The company traded as high as C$2.21 and last traded at C$2.18. Approximately 37,126 shares traded hands during trading, a decline of 12% from the average daily volume of 42,232 shares. The stock had previously closed at C$2.14.
Theratechnologies Stock Performance
The company has a market cap of C$109.43 million, a PE ratio of -13.22, a price-to-earnings-growth ratio of -8.50 and a beta of 1.73. The company has a debt-to-equity ratio of 562.07, a current ratio of 1.10 and a quick ratio of 0.64. The business has a fifty day simple moving average of C$2.36 and a two-hundred day simple moving average of C$1.98.
Theratechnologies Company Profile
Theratechnologies Inc, a biopharmaceutical company, focuses on the development and commercialization of various therapies to address the unmet medical needs in the United States, Canada, and Europe. The company offers EGRIFTA SV for the reduction of excess abdominal fat in human immunodeficiency virus (HIV)-infected patients with lipodystrophy; and Trogarzo for the treatment of HIV-1 infection in heavily treatment-experienced adults with multidrug-resistant HIV-1 infection failing their current antiretroviral regimen.
Featured Stories
- Five stocks we like better than Theratechnologies
- EV Stocks and How to Profit from Them
- Price Plunge in Roblox Presents Opportunity for Robust Gains
- ESG Stocks, What Investors Should Know
- Billions in Buybacks: 4 Stocks Rewarding Shareholders Now
- What is the Dogs of the Dow Strategy? Overview and Examples
- 3 Steel Stocks to Gain Strength as Tariffs Reshape the Market
Receive News & Ratings for Theratechnologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Theratechnologies and related companies with MarketBeat.com's FREE daily email newsletter.
